Authors' Affiliations: Departments of 1Investigational Cancer Therapeutics (Phase I Program) and 2Breast Medical Oncology, MD Anderson Cancer Center, Houston, Texas; 3Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center San Antonio, San Antonio, Texas; 4Gabrail Cancer Center, Canton, Ohio; and 5Angiochem Inc., Montreal, Québec, Canada(2012-02-01時点)